Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shalini Shenoy

Evidence-Based Focused Review of the Status of Hematopoietic Stem Cell Transplantation as Treatment of Sickle Cell Disease and Thalassemia

Blood

English

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey

Frontiers in Immunology

Allergy

Immunology

2020

English

Long-Term Follow-Up After Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Assessment of Safety and Efficacy of PBSC Mobilization With G-CSF and CD34+ Enrichment and PBMNC (CD3+) Addback in Familial Haploidentical (FHI) Adult Donors With Sickle Cell Disease Trait (SCDT) Prior to Allogeneic HSCT of High-Risk SCD Patients

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Unrelated Donor Transplantation in Children With Thalassemia Using Reduced Intensity Conditioning - The URTH Trial

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Treatment of High-Risk Sickle Cell Disease (SCD) With Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation With T-Cell Addback (IND 14359)

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2015

English

Resolution of CGD Related Colitis After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Chronic Granulomatous Disease—Early Results From the 6903 Study of the Primary Immune Deficiency Treatment Consortium (PIDTC)

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report From the Related Donor Safety Study (RDSafe)

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2019

English

Trajectories of Children's Health-Related Quality of Life (HRQL) After Myeloimmuno Ablative Conditioning (MAC) Familial Haploidentical (FHI) T-Cell Depleted (TCD) With T-Cell Addback Stem Cell Transplantation (SCT) for Poor Risk SCD

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2017

English

Natural Killer Cell Reconstitution Following Familial Haploidentical (FHI) CD34 Enriched Stem Cell Transplantation With T-Cell Add Back in Patients With High Risk Sickle Cell Disease (SCD) (IND 14359)

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shalini Shenoy

Evidence-Based Focused Review of the Status of Hematopoietic Stem Cell Transplantation as Treatment of Sickle Cell Disease and Thalassemia

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey

Long-Term Follow-Up After Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders

Assessment of Safety and Efficacy of PBSC Mobilization With G-CSF and CD34+ Enrichment and PBMNC (CD3+) Addback in Familial Haploidentical (FHI) Adult Donors With Sickle Cell Disease Trait (SCDT) Prior to Allogeneic HSCT of High-Risk SCD Patients

Unrelated Donor Transplantation in Children With Thalassemia Using Reduced Intensity Conditioning - The URTH Trial

Treatment of High-Risk Sickle Cell Disease (SCD) With Familial Haploidentical (FHI) T-Cell Depleted (TCD) Stem Cell Transplantation With T-Cell Addback (IND 14359)

Resolution of CGD Related Colitis After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Chronic Granulomatous Disease—Early Results From the 6903 Study of the Primary Immune Deficiency Treatment Consortium (PIDTC)

The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report From the Related Donor Safety Study (RDSafe)

Trajectories of Children's Health-Related Quality of Life (HRQL) After Myeloimmuno Ablative Conditioning (MAC) Familial Haploidentical (FHI) T-Cell Depleted (TCD) With T-Cell Addback Stem Cell Transplantation (SCT) for Poor Risk SCD

Natural Killer Cell Reconstitution Following Familial Haploidentical (FHI) CD34 Enriched Stem Cell Transplantation With T-Cell Add Back in Patients With High Risk Sickle Cell Disease (SCD) (IND 14359)